Equity News
Akers Biosciences (AKER) Stock Spiked 30% on Merger Deal with MyMD Pharmaceuticals
Following the merger deal, Akers has also signed a Securities Purchase Agreementwith certain accredited investors to raise $18 million. Shares of Akers Biosciences, Inc. (AKER) soared on Thursday following the announcement of a merger deal with MyMD Pharmaceuticals. AKER spiked 30% at day’s close to
